Aurora Cannabis Investor Presentation February 2019

Aurora Cannabis presents its global cannabis operations across 23 countries with 11 production facilities and 3 EU GMP certifications. The company highlights its market leadership in medical cannabis, 15 strategic acquisitions since 2016, and 40 clinical studies supporting over 73,000 medical patients served worldwide.